Login / Signup

Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program.

Ja Young JeonSoo Jin LeeSieun LeeSoo Jin KimSeung Jin HanHae Jin KimDae-Jung KimYoung Seol KimJeong Taek WooKyu Jeung AhnMoonsuk NamSei Hyun BaikYongsoo ParkKwan-Woo Lee
Published in: Journal of diabetes investigation (2018)
Metformin was associated with a lower failure risk than were sulfonylureas and meglitinides, but a comparable aGI failure rate.
Keyphrases
  • clinical practice
  • quality improvement
  • type diabetes
  • cardiovascular disease
  • glycemic control
  • open label
  • clinical trial
  • skeletal muscle
  • insulin resistance